FATE - Fate Therapeutics announces pricing of $100M underwritten offering and concurrent private placement March, 19 2024 08:56 AM Fate Therapeutics Inc. 2024-03-19 08:56:58 ET More on Fate Therapeutics Fate Therapeutics Update: A Rally Based On Little Increases Near-Term Risks Seeking Alpha’s Quant Rating on Fate Therapeutics Historical earnings data for Fate Therapeutics Financial information for Fate Therapeutics For further details see: Fate Therapeutics announces pricing of $100M underwritten offering and concurrent private placement